interests.
Correspondence and requests for materials should be addressed to M.T.L. Insulin stimulates glucose transport by promoting exocytosis of the glucose transporter Glut4 (refs 1, 2) . The dynamic processes involved in the trafficking of Glut4-containing vesicles, and in their targeting, docking and fusion at the plasma membrane, as well as the signalling processes that govern these events, are not well understood. We recently described tyrosine-phosphorylation events restricted to subdomains of the plasma membrane that result in activation of the G protein TC10 (refs 3, 4). Here we show that TC10 interacts with one of the components of the exocyst complex, Exo70. Exo70 translocates to the plasma membrane in response to insulin through the activation of TC10, where it assembles a multiprotein complex that includes Sec6 and Sec8. Overexpression of an Exo70 mutant blocked insulinstimulated glucose uptake, but not the trafficking of Glut4 to the plasma membrane. However, this mutant did block the extracellular exposure of the Glut4 protein. So, the exocyst might have a crucial role in the targeting of the Glut4 vesicle to the plasma membrane, perhaps directing the vesicle to the precise site of fusion.
To search for potential effectors of TC10 that have a role in insulin-stimulated glucose transport, we screened a yeast twohybrid complementary-DNA library derived from 3T3L1 adipocytes with a constitutively active mutant form of human TC10a 5 , and identified two clones encoding the full-length sequence of Exo70, a component of the exocyst complex, which has been implicated in the tethering or docking of secretory vesicles 6, 7 . To explore the specificity of the interaction of TC10 with Exo70, we cotransfected 293T cells with myc-tagged Exo70 and haemagglutinin (HA)-tagged, constitutively active forms of mouse TC10a, Rho1, Rac1 or Cdc42 cDNAs [8] [9] [10] [11] (Fig. 1a ). Exo70 could be co-precipitated with TC10, but not with Rho, Rac or Cdc42, indicating that its interaction with TC10 is specific. TC10b could also be co-precipitated with Exo70 (data not shown). To evaluate whether Exo70 is a potential effector of TC10, we incubated lysates derived from cells expressing different forms of HA-tagged TC10 with a glutathione S-transferase (GST)-Exo70 fusion protein, to examine binding in vitro (Fig. 1b) . Exo70 bound to the constitutively active mutant TC10a(Q67L), but not to the dominant-interfering TC10a(T23N). Identical results were obtained with the corresponding mutants TC10b(T25N) and TC10b(Q69L) (data not shown). To confirm that the interaction of TC10 with Exo70 was GTP-dependent, lysates expressing TC10 were loaded with GDP or a non-hydrolysable form of GTP (GTPgS) in vitro, and incubated with GST-Exo70. Exo70 bound weakly to the GDP-bound form of TC10, and strongly to the GTP-bound, activated state of the protein. These data show that Exo70 interacts with TC10 in a GTP-dependent manner.
To study the function of Exo70 in glucose transport, we sought to map its TC10 binding site through a series of deletion mutants. Exo70 has only one putative protein-protein interaction region, a coiled-coil domain in the amino terminus (Fig. 1c) . We deleted amino acids 1-384 of Exo70, and also prepared constructs expressing only amino acids 1-384, 1-99 or 100-384, and evaluated the ability of the mutants to bind constitutively active TC10a(Q67L) in a co-precipitation experiment. Whereas wild-type Exo70 (Exo70-WT) bound to TC10, Exo70(385-653) (Exo70-C) did not. Moreover, an Exo70 fragment containing only amino acids 1-384 (Exo70-N) bound to TC10, whereas Exo70 containing amino acids 1-99, which comprised the coiled-coil domain, bound weakly, and Exo70 containing residues 100-384 also bound weakly. These data indicate that amino acids 1-384 of Exo70 are both necessary and sufficient for binding to TC10, but that this interaction requires more than the coiled-coil domain ( Fig. 1d and Supplementary Fig. 1 ).
We analysed the intracellular localization of Exo70 by immunohistochemistry, and evaluated its potential regulation by insulin and TC10. 3T3L1 adipocytes were transfected with myc-Exo70 plus or minus TC10 and its mutants. As shown in Fig. 2a , b, myc-Exo70 was distributed diffusely throughout the intracellular region. Coexpression of TC10 or its inactive mutant TC10(T23N) did not influence the localization of overexpressed myc-Exo70. By contrast, Exo70 was localized at the plasma membrane when co-expressed with the constitutively active mutant TC10(Q67L), indicating that TC10 activation stimulates the translocation of Exo70. We also examined whether the amino-terminal fragment of Exo70 (Exo70-N) translocated to the plasma membrane after expression of active TC10. Unlike the wild-type form of the protein, this fragment did letters to nature not translocate to the membrane when co-expressed with active TC10, despite the fact that it can bind to the protein in vitro or after co-expression in 293T cells (Fig. 1d) . These data suggest that the carboxy-terminal sequences in Exo70 are required for the movement of the protein in adipocytes, possibly owing to an interaction with another protein.
The translocation of Exo70 to the plasma membrane by activated TC10 suggested that insulin might induce a similar redistribution of the protein. Following transfection with myc-Exo70, cells were stimulated with insulin, and the localization of the protein was examined by immunohistochemistry. Insulin stimulation resulted in the translocation of Exo70 to the plasma membrane. This event was blocked by the co-transfection of cells with the inactive mutant TC10(T23N) (Fig. 2c, d ). By contrast, co-expression with the wildtype or constitutively active mutant of TC10 did not block the effect of insulin (data not shown). Interestingly, as observed above with the overexpression of active TC10, insulin failed to stimulate the translocation of the amino-terminal fragment of Exo70 to the plasma membrane.
The observation that insulin can recruit Exo70 to the plasma membrane by way of TC10 suggests that insulin might promote the assembly of the exocyst complex through an interaction between TC10 and Exo70. The exocyst complex is thought to assemble before the fusion of secretory vesicles with the plasma membrane [12] [13] [14] . This complex includes the proteins Sec6 and Sec8, which have been shown to regulate the late stage of exocytosis in MDCK cells 15, 16 . Unfortunately, antibodies to Sec6 and Sec8 could not be used for immunohistochemistry. So, to evaluate the localization of these endogenous proteins, we fractionated cell lysates derived from 3T3L1 adipocytes stimulated with or without insulin. Sec6 and Sec8 were found in cytosolic and low-density microsomal (LDM) fractions, with a small amount found in the plasma-membrane fraction. Treatment of cells with insulin reduced the appearance of the two proteins in the cytoplasm and low-density microsomes, with a corresponding increase in the plasma-membrane fraction (Fig. 3a) .
We also evaluated whether Exo70 formed a complex with Sec6 and Sec8. As shown in Fig. 3b , endogenous Sec6 bound to Sec8, as assayed by co-precipitation. This interaction was insulin-indepen- Figure 1 Exo70 interacts with activated TC10. a, Exo70 specifically interacts with TC10. 293T cells were co-transfected with myc-Exo70 and HA-tagged, constitutively active forms of TC10a(Q67L), RhoA(G14V), Rac1(G12V) and Cdc42(Q61L). Lysates were immunoprecipitated (IP) with an anti-myc antibody, followed by blotting with anti-HA antibody. b, Exo70 interacts with TC10 in a GTP-dependent manner. 293T cells were transfected with HA-tagged wild-type TC10a, its constitutively active Q67L mutant, or its inactive T23N mutant. Cell lysates were preincubated with either 100 mM GTPgS or 1 mM GDP, and then incubated with glutathione-Sepharose-bound GST-Exo70. Precipitates were analysed by immunoblot analysis with anti-HA antibody. Identical results were obtained with TC10b (data not shown). c, Schematic of Exo70 and its deletion mutants. cc, coiled-coil. d, Interaction of TC10 with Exo70 mutants. 293T cells were co-transfected with HA-TC10a(Q67L) and myc-tagged wild-type Exo70 or mutants containing amino acids 1-384 (Exo70-N), 385-653 (Exo70-C), 1-99, 100-384 or empty vector. Lysates were immunoprecipitated with anti-myc antibody, and immunopellets were analysed by blotting with anti-HA antibody. Exo70 is translocated to the plasma membrane by insulin. a, Overexpression of constitutively active TC10(Q75L) recruits Exo70 to the plasma membrane (PM). 3T3L1 adipocytes were co-transfected with myc-Exo70-WT or myc-Exo70-N with vector only, HA-tagged wild-type TC10, or its Q75L or T31N mutants. Cells were fixed and stained with anti-myc polyclonal antibody to detect myc-Exo70, and with anti-HA monoclonal antibody to detect HA-TC10, followed by Alexa 594 goat anti-rabbit IgG and Alexa 488 goat anti-mouse IgG. Fluorescence was visualized by confocal laser scanning microscopy. Images represent four independent determinations. b, d, Graphical representation of data from three independent experiments. *Significant difference, P , 0.0001. c, Exo70 translocates to the plasma membrane in response to insulin. 3T3L1 adipocytes were electroporated with myc-Exo70-WT or myc-Exo70-N with or without HA-TC10(T31N), serum-starved, and treated with or without insulin for 5 min. Cells were fixed and stained with anti-myc antibody followed by Alexa 594 goat anti-mouse IgG.
dent. Moreover, both wild-type Exo70 and its amino-terminal fragment bound to endogenous Sec8 (Fig. 3c, d ). Interestingly, whereas the amino-terminal region of Exo70 bound to Sec8, a fragment of the protein containing only amino acids 385-653 did not (data not shown). So, Exo70 appears to exist in a preformed complex with Sec6 and Sec8, through an interaction in the aminoterminal region of Exo70. This multiprotein complex is then translocated to the plasma membrane in response to insulin. As the amino-terminal fragment of Exo70 fails to translocate to the plasma membrane in response to insulin or active TC10, this mutant form of the protein might also block the assembly of the exocyst complex at the cell surface. Cells were transfected with the myc-tagged wild-type or amino-terminal fragment of Exo70 (Fig. 3e) , treated with insulin, and fractionated as detailed above. As determined by immunohistochemical analysis (Fig. 2) , insulin stimulated the translocation of wild-type Exo70 to the plasma membrane. However, the amino-terminal fragment remained mainly in the cytoplasm, and the localization of this protein was not influenced by insulin. Sec8 also translocated to the membrane in response to insulin in cells that expressed wild-type Exo70.
However, expression of the mutant form of the protein blocked the translocation of endogenous Sec8. These data indicate that the amino-terminal fragment of Exo70 can act as a dominant-negative mutant, presumably blocking the insulin-stimulated assembly of the exocyst complex at the plasma membrane.
The exocyst complex is thought to have an important role in targeted exocytosis. To evaluate whether the interaction between TC10 and Exo70 is involved in Glut4 vesicle trafficking, we overexpressed Exo70 and its mutants in 3T3L1 adipocytes by electroporation, and assayed 2-deoxyglucose uptake 17 (Fig. 4a) . In cells transfected with an empty vector, insulin produced a fivefold increase in 2-deoxyglucose uptake. Overexpression of wild-type Exo70 led to a 48% increase in insulin-stimulated glucose uptake over that observed in cells transfected with an empty vector, although basal activity was not significantly changed. By contrast, the amino-terminal fragment of Exo70, which blocks the assembly of the exocyst complex, produced a 40% inhibition of insulinstimulated transport compared with control, although basal activity was again unaffected. In these experiments, less than 50% of the cells were transfected by the electroporation method, indicating that Figure 3 Components of the exocyst complex translocate to the plasma membrane in response to insulin. a, Sec6 or Sec8 translocate to the plasma membrane in response to insulin stimulation. After insulin stimulation, cells were placed on ice and washed three times with ice-cold PBS. Membrane fractionation was carried out using 3T3L1 adipocytes as reported 29 , and endogenous Sec6 and Sec8 were detected by monoclonal antibodies. b, Sec8 interacts with Sec6. The cell lysates from 3T3L1 adipocytes were incubated with a Sec8 monoclonal antibody and blotted with a Sec6 antibody. c, Sec8 and Exo70 interact. 3T3L1 adipocytes were transfected with myc-Exo70. Cells were stimulated with 100 nM insulin for 10 min. Cell lysates were incubated with a Sec8 monoclonal antibody and blotted with an anti-myc polyclonal antibody. d, Sec8 interacts with Exo70-WT and Exo70-N. Lysates were prepared as described in c from 3T3L1 adipocytes transfected with myc-Exo70-WT or myc-Exo70-N. e, Exo70-N blocks membrane translocation of Sec8. Membrane fractionation was carried out using 3T3L1 adipocytes transfected with myc-Exo70-WT and myc-Exo70-N after insulin stimulation. Endogenous Sec8 and caveolin-1 were detected by western blotting using the plasma-membrane fraction. The means (and standard deviations) of three independent determinations are shown in graphical form. *Significant difference, P , 0.005. most of the insulin-stimulated glucose transport was blocked by overexpression of the Exo70-N mutant.
As mentioned above, insulin-stimulated glucose transport results from the translocation of the Glut4 protein to the cell surface. So, we next evaluated the effect of Exo70 on the translocation of a Glut4-enhanced green fluorescent protein (eGFP) fusion protein in 3T3L1 adipocytes. Cells were co-transfected with Glut4-eGFP and with wild-type or mutant forms of Exo70. Insulin stimulated the translocation of Glut4-eGFP in 90% of the cells transfected with vector alone, as detected by increased rim fluorescence. Co-expression with wild-type Exo70 had no impact on basal or insulin-stimulated translocation. Interestingly, co-expression with the amino-terminal fragment of Exo70 was also without effect on Glut4-eGFP translocation, despite the clear inhibition of glucose transport observed by overexpression of this mutant (Fig. 4b) .
The inhibition of insulin-stimulated glucose uptake in the face of no effect on Glut4 translocation by the Exo70 mutant indicated that the protein might influence the targeting or docking of Glut4 to the plasma membrane, rather than the translocation process. To explore this possibility in more detail, we co-expressed the Exo70 mutants with a Glut4-GFP construct that was HA-tagged in its first extracellular loop 18 ( Fig. 4c) . This double-tagged form of Glut4 can be detected by the fluorescence of GFP, and simultaneously by immunodetection of the HA tag at the cell surface in nonpermeabilized cells, thus representing a method to evaluate both the translocation and extracellular exposure of Glut4 (ref. 18) . In the absence of insulin, there was no cell-surface staining of HA-Glut4-GFP with anti-HA, whereas insulin treatment produced a strong signal. Co-transfection of cells with wild-type Exo70 significantly increased the cell-surface staining of HA-Glut4-GFP, as detected by anti-HA antibodies, consistent with the increase in glucose transport produced by overexpression of the protein. By contrast, cotransfection of cells with the amino-terminal fragment of Exo70 completely blocked the appearance of HA-Glut4-GFP at the cell surface (Fig. 4c, d ), indicating that Exo70 might have a crucial role in the membrane targeting of Glut4. An inhibitory mutant of TC10 also blocked the cell-surface exposure of exofacial tagged Glut4 (Supplementary Fig. 2 ).
The translocation of the insulin-responsive glucose transporter Glut4 from intracellular membranes to the cell surface is likely to involve numerous steps, typical of vesicular transport in other systems. These may include mechanisms for the tethering of the vesicle to target membranes, where it can come into contact with the docking and fusion machinery. For many exocytotic processes, this step is mediated by the exocyst, an evolutionarily conserved octameric complex that targets vesicles to specific sites of the plasma membrane 19 . Data presented here suggest that the exocyst complex assembles at the plasma membrane of fat cells in response to insulin, through the association of Exo70 with activated TC10, and has a role in the tethering of the Glut4 vesicle, where it can come into proximity with the SNARE (SNAP receptor) complexes involved in docking and fusion 20, 21 . The Rab proteins, which are mammalian homologues of the yeast exocyst component Sec4, might mediate this tethering step. Rab4 has been found in Glut4 vesicles, and translocates to the plasma membrane in response to insulin [22] [23] [24] [25] . Moreover, we have also shown that TC10 can interact with the effector protein CIP4, which is required for Glut4 translocation 26 . So, TC10 might engage multiple effectors that influence both Glut4 translocation and tethering of the vesicle at the plasma membrane. This possibility is under investigation.
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Methods
Yeast two-hybrid screen
The cDNA encoding full-length human TC10(Q75L) was amplified by polymerase chain reaction (PCR) using the plasmid pKH3-TC10(Q75L) (a gift from I. Macara, University of Virginia, Charlottesville) as a template, and a yeast two-hybrid cDNA library derived from 3T3L1 adipocyte messenger RNA was screened as described previously 26 .
Expression constructs
To generate a mammalian expression vector, full-length Exo70 cDNA was subcloned into the pCS2 vector. To construct deletion mutants, Exo70 cDNA was digested with NcoI and religated, generating Exo70-N or Exo70-C mutants. For 1-99 or 100-384 mutants, Exo70 was PCR-amplified from pCS2-Exo70 using oligonucleotides containing EcoRI/XhoI restriction sites, and subcloned into pCS2 at EcoRI/XhoI.
In vitro GST pull-down assay GST or GST-Exo70 fusion proteins were expressed in the BL21(DE3) pLysS Escherichia coli strain and purified. Cell lysates were prepared for immunoprecipitation as described below, and incubated with either GST alone or GST-Exo70 bound to glutathioneSepharose beads (Amersham Pharmacia) for 2 h at 4 8C. For GTP-binding experiments, cell lysates were loaded in vitro with either 1 mM GDP or 100 mM GTPgS for 30 min at 37 8C before incubating with GST fusion proteins 27 . The beads were washed five times with lysis buffer, resuspended in sample buffer, subjected to SDS-polyacrylamide gel electrophoresis (SDS-PAGE), and analysed by immunoblotting with anti-myc monoclonal antibody or polyclonal antibody (Santa Cruz Biotechnology) or anti-HA monoclonal antibody (Santa Cruz Biotechnology).
Immunoprecipitation and immunoblotting
Cell lysates were prepared as described using 1% Triton X-100 (ref. 4) . Lysates were then incubated with the indicated antibodies for 2 h at 4 8C. The immune complexes were precipitated with protein A or G agarose (Amersham Pharmacia) for 1 h at 4 8C, washed extensively with lysis buffer, resolved in 10-20% gradient SDS-PAGE, and analysed by immunoblotting. All immunoblots were developed by enhanced chemiluminesence (Amersham Pharmacia). Anti-Sec6 (9H5) and Sec8 (2E9) monoclonal antibodies were obtained from Calbiochem, and anti-caveolin-1 polyclonal antibody was obtained from Transduction Laboratories.
Immunofluorescence microscopy
For immunofluorescence studies, electroporated cells were processed as described 17 . To detect myc-Exo70, cells were stained with anti-myc monoclonal antibody or polyclonal antibody (Santa Cruz Biotechnology). To detect HA-TC10, cells were stained with anti-HA monoclonal antibody (Santa Cruz Biotechnology). After incubation with primary antibodies, cells were incubated with Alexa 488 or Alexa 594 goat anti-mouse or anti-rabbit immunoglobulin (IgG), obtained from Molecular Probes. Images were captured by using an Olympus FV300 confocal laser scanning microscope.
Assays of Glut4-eGFP translocation and HA-Glut4-GFP Glut4-eGFP translocation assays were performed as described 28 . The HA-Glut4-GFP construct was a gift from S. W. Cushman (National Institutes of Health, Maryland). The method was followed as described previously 
